Aerovate Therapeutics Inc(NASDAQ:AVTE) 
Aerovate Therapeutics is a clinical stage biopharmaceutical company whose mission is to advance novel therapeutics and to help people with rare cardiopulmonary diseases gain control over their health, and their lives.
Website: https://www.aerovatetx.com/
Founded: 2018
IPO Price: $14 (Jun 29, 2021)
CEO: Tim Noyes
Sector:
Industry:
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 86.36
H 90.21
L 85.66
C 87.06
V 94,583
10EMA 87.06
20EMA 87.06
60EMA 87.06
120EMA 87.06
250EMA 87.06